Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Werthenstein Biopharma is a Swiss-based subsidiary of MSD (known as Merck & Co. in the U.S. and Canada) that serves as a strategic site for pharmaceutical development and manufacturing. Located in Schachen, the facility is a global center of excellence for the production, testing, and distribution of clinical trial supplies, ensuring that investigational medicines reach study sites worldwide. The site specializes in the primary and secondary packaging of both small molecules and biologics, as well as quality control testing and stability studies. By bridging the gap between research and clinical application, Werthenstein Biopharma plays a vital role in MSD's global R&D engine. The facility is highly automated and supports a wide range of therapeutic areas within the MSD portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Werthenstein Biopharma.